The US government has said it will substantially reduce the use of chimpanzees in biomedical research and send into retirement most of the 360 chimpanzees it currently owns or supports.
The National Institutes of Health (NIH) said Wednesday it accepted most of the recommendations made by an independent advisory council for the use of chimpanzees in NIH-funded research, Xinhua reported.
It will retain but not breed about 50 chimpanzees for future biomedical research, the NIH said, adding that the rest 310 chimpanzees designated for retirement could eventually join more than 150 others already in sanctuaries.
Francis Collins, director of the NIH, said that he believed greatly reducing the use of chimpanzees in biomedical research is "scientifically sound and the right thing to do".
"New scientific methods and technologies have rendered their use in research largely unnecessary," Collins said in a statement. "Their likeness to humans has made them uniquely valuable for certain types of research, but also demands greater justification for their use."
Earlier this month, the US Fish and Wildlife Service announced a proposal to classify both wild and captive chimpanzees as endangered.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
